VYNE Therapeutics
VYNE
VYNE
21 hedge funds and large institutions have $1.54M invested in VYNE Therapeutics in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
21
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$18K | |
| 2 | +$10.4K | |
| 3 | +$3.23K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.09K |
| 5 |
JPMorgan Chase & Co
New York
|
+$552 |
Top Sellers
| 1 | -$40.8K | |
| 2 | -$16.9K | |
| 3 | -$3.65K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$3.14K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.44K |